FDA Inspection 1031605 — Janssen Pharmaceuticals, Inc
The FDA completed an inspection of Janssen Pharmaceuticals, Inc on Oct 6, 2017 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 6, 2017
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Titusville, NJ (United States)